Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Announces David Pernock as President and Chief Commercial Officer 12/19/16 Eagle Pharmaceuticals Reports Positive Results from Pivotal Animal Study Supporting the Efficacy of RYANODEX for Exertional Heat Stroke 12/13/16 Eagle Pharmaceuticals to Present at Piper Jaffray 28th Annual Healthcare Conference 11/21/16 Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Therapeutics Marking Entry into Biosimilar Market 11/11/16 Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Ryanodex in Exertional Heat Stroke 11/11/16 Eagle Pharmaceuticals to Present at Jefferies 2016 London Healthcare Conference 11/9/16 Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results 11/9/16 CMS Establishes Unique J-Code for BENDEKA® (bendamustine hydrochloride) Injection 11/2/16 Final Reminder: Eagle Pharmaceuticals to Host 2016 Investor Day in New York City 11/1/16 Eagle Pharmaceuticals Announces Positive Initial Results of Animal Study Exploring Use of Ryanodex in MDMA (Ecstasy) Induced Hyperthermia Conducted at the National Institutes of Health 10/31/16 Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page
